Rhenman & Partners Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-159,500
Closed -$13.9M 94
2025
Q2
$13.9M Buy
159,500
+4,500
+3% +$353K 1.76% 22
2025
Q1
$10.6M Buy
+155,000
New +$12.6M 1.22% 31
2024
Q4
Sell
-87,000
Closed -$5.83M 94
2024
Q3
$5.83M Sell
87,000
-30,000
-26% -$2.46M 0.47% 63
2024
Q2
$13.3M Sell
117,000
-21,500
-16% -$2.72M 1.27% 29
2024
Q1
$19.2M Buy
138,500
+28,500
+26% +$3.58M 1.82% 23
2023
Q4
$13.6M Buy
110,000
+65,000
+144% +$6.64M 1.36% 28
2023
Q3
$4.2M Buy
+45,000
New +$5.07M 0.45% 56
2018
Q1
Sell
-282,500
Closed -$4.05M 94
2017
Q4
$4.05M Sell
282,500
-197,500
-41% -$2.57M 0.55% 63
2017
Q3
$5.87M Buy
480,000
+62,480
+15% +$1.1M 0.75% 53
2017
Q2
$7.63M Buy
417,520
+189,920
+83% +$3.51M 1.1% 35
2017
Q1
$4.82M Sell
227,600
-111,600
-33% -$2.18M 0.76% 51
2016
Q4
$5.06M Buy
339,200
+79,200
+30% +$1.4M 0.97% 38
2016
Q3
$5.7M Buy
260,000
+40,000
+18% +$890K 0.91% 39
2016
Q2
$4.36M Sell
220,000
-80,000
-27% -$1.36M 0.77% 51
2016
Q1
$5.09M Sell
300,000
-120,000
-29% -$2M 1.01% 38
2015
Q4
$8.6M Buy
420,000
+84,000
+25% +$1.75M 1.3% 32
2015
Q3
$7.21M Sell
336,000
-32,000
-9% -$714K 1.15% 36
2015
Q2
$7.36M Buy
368,000
+60,000
+19% +$1.05M 1.04% 34
2015
Q1
$4.8M Buy
308,000
+52,000
+20% +$786K 0.86% 45
2014
Q4
$3.52M Sell
256,000
-168,000
-40% -$2.06M 1.02% 33
2014
Q3
$4.24M Buy
424,000
+24,000
+6% +$245K 1.3% 29
2014
Q2
$3.97M Buy
400,000
+84,848
+27% +$752K 1.18% 26
2014
Q1
$3.26M Buy
315,152
+7,152
+2% +$73.9K 0.99% 35
2013
Q4
$2.73M Buy
+308,000
New +$2.44M 1.09% 39

Other funds holding DXCM